The Johns Hopkins Hospital is the teaching hospital and biomedical research facility of the Johns Hopkins School of Medicine, located in Baltimore, Maryland, U.S. It was founded in 1889 using money from a bequest of over $7 million by city merchant, banker/financier, civic leader and philanthropist Johns Hopkins.

There are 1,091 beds in Johns Hopkins Hospital.

During the past decade, Johns Hopkins Hospital conducted 609 clinical trials. In the 10-year time frame, 609 clinical trials started and 312 clinical trials were completed, i.e. on average, 51.2% percent of trials that started reached the finish line to date. In the past 5 years, 254 clinical trials started and 168 clinical trials were completed. i.e. 66.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Hospital" #1 sponsor was "Johns Hopkins University" with 327 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 83 trials sponsored, "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 55 trials sponsored, "Abbott Medical Devices" with 19 trials sponsored and "Pfizer" with 19 trials sponsored. Other sponsors include 639 different institutions and companies that sponsored additional 370 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Hospital" #1 collaborator was "Johns Hopkins University" with 60 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 50 trials as a collaborator, "National Institutes of Health (NIH)" with 19 trials as a collaborator, "Massachusetts General Hospital" with 14 trials as a collaborator and "National Cancer Institute (NCI)" with 14 trials as a collaborator. Other collaborators include 1010 different institutions and companies that were collaborators in the rest 549 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Hospital" are "HIV Infections" (111 trials), "Prostate Cancer" (39 trials), "Cystic Fibrosis" (30 trials), "Atrial Fibrillation" (18 trials) and "Breast Cancer" (18 trials). Many other conditions were trialed in "Johns Hopkins Hospital" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Hospital" are "Drug" (593 trials), "Device" (186 trials), "Other" (138 trials), "Procedure" (101 trials) and "Behavioral" (62 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (119 trials), "Zidovudine" (30 trials), "Indinavir sulfate" (11 trials), "Lamivudine" (10 trials) and "Nelfinavir mesylate" (9 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Hospital" are 1020 trials for "All" genders, 66 trials for "Male" genders and 60 trials for "Female" genders.

Currently, there are 297 active trials in "Johns Hopkins Hospital". 3 are not yet recruiting, 187 are recruiting, 92 are Active, not recruiting, and 15 are Enrolling by invitation. In total, there were 635 completed trials in Johns Hopkins Hospital, undefined suspended trials, and 129 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Hospital, 128 "Phase 1" clinical trials were conducted, 300 "Phase 2" clinical trials and 204 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 47 trials, and there were also 312 trials that are defined as “Not Applicable".